Ardena acquires Idifarma, adding spray drying technology and high potency capabilities.
Ardena—a European contract development and manufacturing organization (CDMO) with services spanning the full development life cycle—announced in a Sept. 1, 2021, press release that it has acquired Idifarma, a contract manufacturer of niche and highly-potent generic and innovative drugs that’s based in Pamplona, Spain. With the acquisition, there are now seven Ardena facilities in Europe, including its headquarters in Ghent, Belgium, three sites in the Netherlands, and two sites in Northern Europe (Sweden and Latvia).
Established in 2011, Idifarma offers various services spanning the full pharma lifecycle for highly potent drugs. Its capabilities include a platform for an accelerated path to clinic and spray drying processes that resolve solubility issues.
“At Ardena, our goal is to become a single source contractor offering an integrated set of services to meet chemical, pharmaceutical and bio-analytical needs that arise throughout the clinical supply chain, from lab to patient. This is the main driver of our M&A strategy,” Harry Christiaens, CEO of Ardena, said in a company press release. “We’re delighted to welcome Idifarma who share the science-led approach needed to deliver valuable and integrated solutions for our biopharma customers globally. The combination of Idifarma and Ardena will also create potential to accelerate growth at the Pamplona facility.”
Source: Ardena
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.